2022 SPILF - Clinical Practice guidelines for the diagnosis and treatment of disco-vertebral infection in adults.

Disco-vertebral infection Spine infection Spondylodiscitis Vertebral bone and joint infection Vertebral osteomyelitis

Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 08 12 2022
revised: 12 12 2022
accepted: 10 01 2023
medline: 8 5 2023
pubmed: 24 1 2023
entrez: 23 1 2023
Statut: ppublish

Résumé

These guidelines are an update of those made in 2007 at the request of the French Society of Infectious Diseases (SPILF, Société de Pathologie Infectieuse de Langue Française). They are intended for use by all healthcare professionals caring for patients with disco-vertebral infection (DVI) on spine, whether native or instrumented. They include evidence and opinion-based recommendations for the diagnosis and management of patients with DVI. ESR, PCT and scintigraphy, antibiotic therapy without microorganism identification (except for emergency situations), therapy longer than 6 weeks if the DVI is not complicated, contraindication for spinal osteosynthesis in a septic context, and prolonged dorsal decubitus are no longer to be done in DVI management. MRI study must include exploration of the entire spine with at least 2 orthogonal planes for the affected level(s). Several disco-vertebral samples must be performed if blood cultures are negative. Short, adapted treatment and directly oral antibiotherapy or early switch from intravenous to oral antibiotherapy are recommended. Consultation of a spine specialist should be requested to evaluate spinal stability. Early lifting of patients is recommended.

Identifiants

pubmed: 36690329
pii: S2666-9919(23)00009-X
doi: 10.1016/j.idnow.2023.01.007
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Practice Guideline Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104647

Investigateurs

Géraldine Bart (G)
Pascal Coquerelle (P)
Stéphane Corvec (S)
Anne Cotten (A)
Marion Couderc (M)
E Denes (E)
Arnaud Dupeyron (A)
Sophie Godot (S)
Marion Grare (M)
A Homs (A)
Brigitte Lam (B)
Jean Philippe Lavigne (J)
V Lemoing (V)
Edouard Pertuiset (E)
P Ribinik (P)
France Roblot (F)
Eric Senneville (E)
Jean Philippe Talarmin (J)
I Tavares Figueiredo (I)
Marie Titeca (M)
Valérie Zeller (V)

Informations de copyright

Copyright © 2023. Published by Elsevier Masson SAS.

Auteurs

M Lacasse (M)

Medecine Interne et Maladies Infectieuses, 2 Bd Tonnelé, CHU Bretonneau, 37044 Tours Cedex 09, France.

S Derolez (S)

Rhumatologie, 125 rue de Stalingrad, CHU Avicenne, 93000 Bobigny, France.

E Bonnet (E)

Maladies Infectieuses, Pl. Dr Baylac, CHU Purpan, 31000 Toulouse, France. Electronic address: bonnet.e@chu-toulouse.fr.

A Amelot (A)

Neurochirurgie, 2 Bd Tonnelé, CHU Bretonneau, 37044 Tours Cedex 09, France.

B Bouyer (B)

Chirurgie orthopédique et traumatologique, CHU de Bordeaux, Place Amélie Raba-léon, 33076 Bordeaux, France.

R Carlier (R)

Imagerie, Hôpital Raymond Poincaré, 104 Bd R Poincaré, 92380 Garches, France.

G Coiffier (G)

Rhumatologie, GH Rance-Emeraude, Hôpital de Dinan, 22100 Dinan, France.

J P Cottier (JP)

Radiologie, 2 Bd Tonnelé, CHU Bretonneau, 37044 Tours Cedex 09, France.

A Dinh (A)

Maladies Infecteiuses, CHU Raymond Poicaré, 92380 Garches, France.

I Maldonado (I)

Radiologie, 2 Bd Tonnelé, CHU Bretonneau, 37044 Tours Cedex 09, France.

F Paycha (F)

Médecine Nucléaire, Hôpital Lariboisière, 2 rue Ambroise Paré 75010 Paris, France.

J M Ziza (JM)

Rhumatologie et Médecine Interne. GH Diaconesses Croix Saint Simon, 75020 Paris, France.

P Bemer (P)

Microbiologie, CHU de Nantes, 1 Place A. Ricordeau, Nantes 44000 Cedex 1, France.

L Bernard (L)

Medecine Interne et Maladies Infectieuses, 2 Bd Tonnelé, CHU Bretonneau, 37044 Tours Cedex 09, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH